Evidence map›Paper›PMID 38396958›Full record

ArticleInternational journal of molecular sciences2024

Cytokine Signaling in Pediatric Kidney Tumor Cell Lines WT-CLS1, WT-3ab and G-401.

Elizaveta Fasler-Kan, Milan Milošević, Sabrina Ruggiero, Nijas Aliu, Dietmar Cholewa, Frank-Martin Häcker, Gabriela Dekany, Andreas Bartenstein, Steffen M Berger

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Elizaveta Fasler-KanDepartment of Pediatric Surgery, Children's Hospital, Inselspital Bern, University of Bern, CH-3010 Bern, Switzerland.
Milan MiloševićDepartment of Pediatric Surgery, Children's Hospital, Inselspital Bern, University of Bern, CH-3010 Bern, Switzerland.
Sabrina RuggieroDepartment of Pediatric Surgery, Children's Hospital, Inselspital Bern, University of Bern, CH-3010 Bern, Switzerland.
Nijas AliuDepartment of Human Genetics, Inselspital Bern, University of Bern, CH-3010 Bern, Switzerland.
Dietmar CholewaDepartment of Pediatric Surgery, Children's Hospital, Inselspital Bern, University of Bern, CH-3010 Bern, Switzerland.
Frank-Martin HäckerDepartment of Pediatric Surgery, Children's Hospital of Eastern Switzerland, CH-9000 St. Gallen, Switzerland.ORCID 0000-0001-8426-5011
Gabriela DekanyDepartment of Pediatric Surgery, Children's Hospital, Inselspital Bern, University of Bern, CH-3010 Bern, Switzerland.
Andreas BartensteinDepartment of Pediatric Surgery, Children's Hospital, Inselspital Bern, University of Bern, CH-3010 Bern, Switzerland.
Steffen M BergerDepartment of Pediatric Surgery, Children's Hospital, Inselspital Bern, University of Bern, CH-3010 Bern, Switzerland.
University of Bern · CHUniversity of Basel · CH

Funding

KinderInsel Bern Switzerland 000
6 · The paper itself

Abstract

Renal tumors comprise ~7% of all malignant pediatric tumors. Approximately 90% of pediatric kidney tumors comprise Wilms tumors, and the remaining 10% include clear cell sarcoma of the kidney, malignant rhabdoid tumor of the kidney, renal cell carcinoma and other rare renal tumors. Over the last 30 years, the role of cytokines and their receptors has been considerably investigated in both cancer progression and anti-cancer therapy. However, more effective immunotherapies require the cytokine profiling of each tumor type and comprehensive understanding of tumor biology. In this study, we aimed to investigate the activation of signaling pathways in response to cytokines in three pediatric kidney tumor cell lines, in WT-CLS1 and WT-3ab cells (both are Wilms tumors), and in G-401 cells (a rhabdoid kidney tumor, formerly classified as Wilms tumor). We observed that interferon-alpha (IFN-α) and interferon-gamma (IFN-γ) very strongly induced the activation of the STAT1 protein, whereas IL-6 and IFN-α activated STAT3 and IL-4 activated STAT6 in all examined tumor cell lines. STAT protein activation was examined by flow cytometry and Western blot using phospho-specific anti-STAT antibodies which recognize only activated (phosphorylated) STAT proteins. Nuclear translocation of phospho-STAT proteins upon activation with specific cytokines was furthermore confirmed by immunofluorescence. Our results also showed that both IFN-α and IFN-γ caused upregulation of major histocompatibility complex (MHC) class I proteins, however, these cytokines did not have any effect on the expression of MHC class II proteins. We also observed that pediatric kidney tumor cell lines exhibit the functional expression of an additional cytokine signaling pathway, the tumor necrosis factor (TNF)-α-mediated activation of nuclear factor kappa B (NF-κB). In summary, our data show that human pediatric renal tumor cell lines are responsive to stimulation with various human cytokines and could be used as in vitro models for profiling cytokine signaling pathways.

Indexed as

Kidney NeoplasmsTumor Necrosis Factor-alphaCell Line, TumorChildCytokinesHistocompatibility Antigens Class IHLA AntigensHumansInterferon-alphaKidneySTAT1 Transcription FactorCytokinesHistocompatibility Antigens Class IHLA AntigensInterferon-alphaSTAT1 Transcription FactorTumor Necrosis Factor-alphacytokineJAK-STAT pathwaypediatric kidney tumorsignalingWilms tumor

Identifiers

PMID38396958
PMCPMC10889092
OpenAlexW4391811566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.